News

Published on 2 May 2022 on Zacks via Yahoo Finance

Refresh Your Portfolio by Dumping These 5 Toxic Stocks


Article preview image

To get rid of fundamentally weak toxic stocks is just as important as it is to invest in fundamentally strong companies. Toxic companies are usually characterized by huge debt loads and are vulnerable to external shocks. If you want to protect your portfolio health, make sure to identify such toxic stocks and dump them right away.

GoodRx Holdings Inc. GDRX, Insulet Corporation PODD, Vonage Holdings Corp VG, AppLovin Corporation APP and Embraer S.A. ERJ are a few such toxic stocks.

There are always some stocks that illusively scale lofty heights in a given time period. Yet, the good show doesn’t last for these overblown toxic stocks, as their current price is not justified by their fundamental strength. Overpricing of these toxic stocks can be attributed to either an irrational enthusiasm surrounding them or some serious fundamental drawbacks. If you own such bubble stocks for an inordinate period of time, you are bound to see massive erosion of wealth.

NASDAQ.GDRX price evolution
NASDAQ.PODD price evolution
NASDAQ.APP price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential:...

On Thursday, Insulet Corporation (NASDAQ:PODD) reported fourth-quarter adjusted EPS of $1.15, dow...

Benzinga · via Yahoo Finance 22 Feb 2025

Insulet stock price target raised to $293 by Stifel By Investing.com

On Friday, Stifel analysts increased their price target on Insulet Corporation (NASDAQ:PODD) shar...

Investing.com 22 Feb 2025

Insulet stock target raised to $324 by Canaccord Genuity By Investing.com

On Friday, Canaccord Genuity analyst Kyle Rose increased the price target for Insulet Corporation...

Investing.com 22 Feb 2025

Insulet’s (NASDAQ:PODD) Q4: Beats On Revenue, Quarterly Revenue Guidance...

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2024 results beating Wal...

Investing.com 21 Feb 2025

PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins Rise

Insulet's fourth-quarter results benefit from the continued high demand for Omnipod 5.

Zacks 21 Feb 2025

Insulet Corporation's (NASDAQ:PODD) Intrinsic Value Is Potentially 25% Below Its...

Using the most recent financial data, we'll take a look at whether the stock is fairly priced by...

Simply Wall St. · via Yahoo Finance 21 Feb 2025

Insulet Earnings: What To Look For From PODD

Insulet Earnings: What To Look For From PODD Insulin delivery company Insulet Corporation (NASDAQ...

StockStory · via Yahoo Finance 19 Feb 2025

PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EU

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercial...

Zacks · via Yahoo Finance 14 Jan 2025

What Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate?

Insulet Corporation (NASDAQ:PODD) saw a double-digit share price rise of over 10% in the past cou...

Simply Wall St. · via Yahoo Finance 7 Jan 2025

Is Insulet Corporation (NASDAQ:PODD) The Top Stock With Improving Technical...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this pie...

Insider Monkey · via Yahoo Finance 11 Oct 2024